Telix Pharmaceuticals | TLX - Operating Profit

Stock Price
13.70
Daily Change
-0.25 -1.79%
Monthly
24.55%
Yearly
-48.46%
Q2 Forecast
12.67

Telix Pharmaceuticals reported AUD8.04M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Cochlear AUD 261.1M 135.55M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Medical Developments International AUD -36K 444K Dec/2025
Mesoblast USD -30.96M 11.14M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 13.07M Dec/2025
Polynovo AUD 2.06M 1.18M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
ResMed USD 500.3M 37.95M Dec/2025
Sonic Healthcare AUD 435.76M 193.66M Dec/2024